Back to search

Article

Expanding the Reach of RNAi Therapeutics with Next Generation Lipophilic siRNA Conjugates

2021-10-21

Abstract excerpt

<title>Abstract</title> <p>RNA interference (RNAi) therapeutics are a new class of medicines that can address unmet medical needs by silencing disease-causing gene transcripts. While delivery of short interfering RNAs (siRNAs) to hepatocytes has yielded multiple drug approvals, novel delivery solutions are needed to expand the reach of RNAi therapeutics. Here we report that conjugation of 2'-<italic>O</italic>-he...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
28b88cd8-5f1f-5647-afcf-725d2c84a383
DOI
10.21203/rs.3.rs-946835/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Expanding the Reach of RNAi Therapeutics with Next Generation Lipophilic siRNA ConjugatesDOI 10.21203/rs.3.rs-946835/v1
Select a neighboring publication to make it the new centre.